Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations34
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1225
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization24
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing23
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level22
Rapid point of care testing: the next frontier in pharmacogenomics21
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study21
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report19
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters18
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications18
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?17
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison15
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates15
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations14
0.086494922637939